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Background: Supply-demand energy imbalance resulting in myocardial “energy starvation” may contribute to the pathophysiology of heart 
failure in non-ischemic dilated cardiomyopathy (NIDCM). Spironolactone is known to facilitate left ventricular (LV) reverse remodeling and hence 
improvement in NIDCM. Cardiac magnetic resonance imaging (CMR) and [11C] acetate PET imaging were used to assess this hypothesis in NIDCM, 
and that aldosterone blockade facilitates reverse remodeling, improving the LV supply-demand energy imbalance.
methods: 12 subjects with NIDCM underwent CMR and [11C] acetate PET imaging at baseline and after > 6 months of spironolactone therapy. The 
myocardial perfusion index (MPI) was calculated as the normalized rate of myocardial signal augmentation following gadolinium at rest and during 
hyperemia. The myocardial perfusion reserve index (MPRI) compared MPI during adenosine to rest. The monoexponential clearance rate of [11C] 
acetate, kmono was used to calculate the work-metabolic index (WMI), a measurement of LV efficiency.
results: At baseline there was relative hypoperfusion of the subendocardium (MPRI = 1.63) compared to the subepicardium (MPRI= 1.80, P< 
0.001), which improved significantly following spironolactone therapy to 1.80 (P<0.001). The relation of oxidative metabolism to demand, as defined 
by the ratio, kmono/rate-pressure product, increased from 5.5 (min-1/ beats min - mmHg) to 6.4 (P=0.003). The WMI increased from a median of 
3.4 x106 (ml x mmHg/m2) to 5.4x106(P=0.001). Reverse remodeling was observed with increased LVEF by 9% (P=0.002) and LV stroke volume by 
30ml (P=0.002), and decreased LV mass index by 10gm/m2 (P=0.002) and LV wall stress by 47kPA (P< 0.001).
conclusions: NIDCM is associated with subendocardial hypoperfusion coupled to impaired myocardial oxidative metabolism consistent with the 
energy starvation hypothesis. Spironolactone therapy > 6 months was associated with reverse remodeling and with a reduction of subendocardial 
energy starvation and demonstrates this concept for the first time in patients with non-ischemic heart failure.
